Elix, Inc. Begins Collaboration With Shionogi & Co., Ltd. on Elix Synthesize™ (AI Drug Discovery Module) for Verification of Practical Retrosynthetic Analysis
Elix, Inc., an AI drug discovery company with the mission of “Rethinking Drug Discovery” (CEO: Shinya Yuki/Headquarters: Tokyo; hereafter referred to as “Elix”) commenced joint...